➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Merck
McKinsey
Johnson and Johnson
Mallinckrodt

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Litigation Details for Genzyme Corporation v. Genentech, Inc. (C.D. Cal. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Biologic Drugs cited in Genzyme Corporation v. Genentech, Inc.
The biologic drug covered by the patent cited in this case is   Start Trial .

Details for Genzyme Corporation v. Genentech, Inc. (C.D. Cal. 2015)

Date Filed Document No. Description Snippet Link To Document
2016-07-01 77 alterations, deletions or additions[.]’” ECF No. 75-10 at 4 (237). 19 With respect to changes in the amino …antibody.” Cabilly 19 III Patent at 6:66-7:1 (53-54), ECF No. 75-3. The patent contemplates that “[c]hanges…takes issue with the assertion that the Cabilly III patent claims cover 16 Genzyme’s product Lemtrada® in…royalties on that antibody under the Cabilly III patent without suggesting that 19 Genzyme did not require…constant region. See 26 1 The Cabilly III patent issued on April 12, 2011. Lemtrada® was approved External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Colorcon
Johnson and Johnson
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.